ロード中...
Development and testing of AAV-delivered single-chain variable fragments for the treatment of methamphetamine abuse
Methamphetamine (METH) substance abuse disorders have major impact on society, yet no medications have proven successful at preventing METH relapse or cravings. Anti-METH monoclonal antibodies can reduce METH brain concentrations; however, this therapy has limitations, including the need for repeate...
保存先:
| 出版年: | PLoS One |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Public Library of Science
2018
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6025879/ https://ncbi.nlm.nih.gov/pubmed/29958300 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0200060 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|